BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

FASgen, Inc. 

Bayview Medical Campus
Alpha Center, 2nd Floor
5210 Eastern Avenue

Baltimore  Maryland  21224  U.S.A.
Phone: 410-558-9200 Fax: 410-558-9300


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
Company Profile for FASgen, Inc. 10/2/2009 9:02:13 AM    More...
FASgen, Inc. Announces Research and License Agreement With Centocor, Inc. (JNJ) 1/6/2009 6:44:57 AM    More...
FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data 4/18/2008 11:05:11 AM    More...
FASgen, Inc. Diagnostic Tests Identify Ovarian Cancer Progression and Apoptosis 3/27/2008 7:32:56 AM    More...
FASgen, Inc. Announces New Research Discoveries in Lung Cancer 12/28/2007 8:00:48 AM    More...
FASgen, Inc. Announces a New Discovery in Obesity Research 12/21/2007 8:05:52 AM    More...
FASgen, Inc. Announces New Discovery for Treatment of Stroke 12/20/2007 8:28:38 AM    More...
FASgen, Inc. Announces Significant Milestone in Its Cancer Drug Development Program 10/2/2007 8:06:27 AM    More...
FASgen, Inc. Announces New Diagnostic Research Test for Steatohepatitis 6/1/2007 1:13:16 PM    More...
FASgen, Inc. Announces New Diagnostic Research Test for Steatohepititis 5/31/2007 11:16:31 AM    More...
123

//-->